Enrolling
CTN 287: OPT-IN
Optimizing the delivery of HIV post-exposure prophylaxis: A randomized controlled trial of text messaging support and physician to nurse task-shifting
Learn MoreEnrolling
Optimizing the delivery of HIV post-exposure prophylaxis: A randomized controlled trial of text messaging support and physician to nurse task-shifting
Learn MoreOngoing
Effectiveness of early treatment with anti-retroviral therapy in children with HIV
Learn MoreCompleted
Motivational Interviewing in Conjunction with Rapid HIV Testing
Learn MoreReporting
A small group intervention to reduce HIV sexual transmission risk behaviour among HIV-positive men who have sex with men: Gay Positive Sex (GPS)
Learn MoreReporting
On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men
Learn MoreReporting
HIV prevention for gay and bisexual men via reduction of social anxiety and substance use in sexual situations
Learn MoreReporting
Canadian HIV women’s sexual and reproductive health cohort study
Learn MoreReporting
A randomized clinical trial evaluating the role of contingent reinforcement in the engagement and retention of Drug Users in HAART programs: a substudy of CTN 244
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.